Stubborn Tregs limit T-cell therapy
- PMID: 22996654
- DOI: 10.1182/blood-2012-08-445239
Stubborn Tregs limit T-cell therapy
Abstract
In this issue of Blood, Baba and colleagues characterize a residual pool ofCD4+CD25+Foxp3+ regulatory T cells (Tregs) surviving a nonmyeloablative conditioning regimen that undergo robust homeostatic expansion to limit the full potential of adoptive T-cell therapy (ACT) for the treatment of cancer.
Comment on
-
Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.Blood. 2012 Sep 20;120(12):2417-27. doi: 10.1182/blood-2012-02-411124. Epub 2012 Jul 17. Blood. 2012. PMID: 22806892
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources

